Sun Pharmaceutical Industries Limited — Others, 25-03-2025: Trading Window

Sun Pharmaceutical Industries Limited has announced a board meeting on a date to be determined to approve the audited financial results for the financial year ended March 31, 2025. In alignment with its Code of Conduct for Prohibition of Insider Trading, the trading window for Sun Pharma shares will be closed from April 1, 2025, until 48 hours after the results are declared. This move aims to maintain transparency and comply with insider trading regulations. Investors may view this closure as a precautionary measure that could mitigate risks associated with trading ahead of critical financial disclosures, potentially influencing market sentiment.